Final Results and Investor Presentation

AI SummaryClose X

Probiotix Health PLC reported a significant increase in sales for the year ended December 31, 2025, reaching £2.73 million, a 45% rise from £1.88 million in 2024, with gross profit also growing by 46% to £1.48 million. The company successfully reduced its EBITDA loss from continuing operations by 34% to £426,000, while improving its gross profit margin to 54%. Probiotix Health ended the year with a cash balance of £1.27 million and remains fully funded, having launched ten new products during the period. The company noted a positive start to 2026, achieving profitability in the first quarter with a record order book of £1.3 million, up 110%.

Disclaimer*

UK 100

Latest directors dealings